Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention
- 1 November 1998
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 82 (9), 1105-1106
- https://doi.org/10.1016/s0002-9149(98)00565-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial InfarctionCirculation, 1998
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE studyThe Lancet, 1997
- In-Hospital and One-Year Economic Outcomes After Coronary Stenting or Balloon AngioplastyCirculation, 1995
- Improving the results of bail‐out stentingCatheterization and Cardiovascular Diagnosis, 1995
- Predicting the risk of abrupt vessel closure after angioplasty in an individual patientJournal of the American College of Cardiology, 1994
- Incidence, predictors, and management of acute coronary occlusion after coronary angioplastyAmerican Heart Journal, 1994
- Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty. A matched case-control studyJournal of the American College of Cardiology, 1993
- Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profileJournal of the American College of Cardiology, 1992
- Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.Cell Metabolism, 1988